93 related articles for article (PubMed ID: 9156708)
1. [Prognostic role of age and base hormonal levels in infertility treatment].
Rongières-Bertrand C; Olivennes F; Fanchin R; Fernandez H; Righini C; Sarranti L; Hazout A; Glissant M; Frydman R
Contracept Fertil Sex; 1997 Mar; 25(3):202-5. PubMed ID: 9156708
[No Abstract] [Full Text] [Related]
2. The forgotten variable: impact of luteinizing hormone on the prediction of ovarian reserve.
Weghofer A; Feichtinger W
Fertil Steril; 2006 Jan; 85(1):259-61. PubMed ID: 16412772
[TBL] [Abstract][Full Text] [Related]
3. Predicting in vitro fertilization live birth using stimulation day 6 estradiol, age, and follicle-stimulating hormone.
Srouji SS; Mark A; Levine Z; Betensky RA; Hornstein MD; Ginsburg ES
Fertil Steril; 2005 Sep; 84(3):795-7. PubMed ID: 16169429
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of basal hormone levels on ovarian reserve].
Zhao X; Zhang L; Gong S
Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):334-6. PubMed ID: 10806668
[TBL] [Abstract][Full Text] [Related]
5. Value of the day 3 follicle-stimulating hormone measurement.
Wolff EF; Taylor HS
Fertil Steril; 2004 Jun; 81(6):1486-8; discussion 496-7. PubMed ID: 15193463
[TBL] [Abstract][Full Text] [Related]
6. Infertility in the older woman.
Schmidt-Sarosi C
Clin Obstet Gynecol; 1998 Dec; 41(4):940-50. PubMed ID: 9917949
[No Abstract] [Full Text] [Related]
7. Modest follicle-stimulating hormone elevations in younger women: warn but don't disqualify.
Toner JP
Fertil Steril; 2004 Jun; 81(6):1493-5; discussion 496-7. PubMed ID: 15193465
[TBL] [Abstract][Full Text] [Related]
8. Concluding letter from Robert F. Harrison on the predictive value of serum FSH levels.
McDonough PG
Fertil Steril; 2000 Feb; 73(2):421. PubMed ID: 10685557
[No Abstract] [Full Text] [Related]
9. Luteal phase estradiol level: a potential predictive marker for successful pregnancy in in vitro fertilization/intracytoplasmic sperm injection.
Ganesh A; Goswami S; Chattopadhyay R; Chakraborty C; Chaudhury K; Chakravarty BN
Fertil Steril; 2009 Apr; 91(4):1018-22. PubMed ID: 18359023
[TBL] [Abstract][Full Text] [Related]
10. Assessment of ovarian reserve by using the follicle-stimulating hormone isoform distribution pattern to predict the outcome of in vitro fertilization.
Letterie GS; Lee JS; Padmanabhan V
Fertil Steril; 2006 Nov; 86(5):1547-9. PubMed ID: 16999956
[TBL] [Abstract][Full Text] [Related]
11. Follicle-stimulating hormone and estradiol levels independently predict the success of assisted reproductive technology treatment.
Frazier LM; Grainger DA; Schieve LA; Toner JP
Fertil Steril; 2004 Oct; 82(4):834-40. PubMed ID: 15482756
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of follicular reserve].
Belaisch-Allart J
Contracept Fertil Sex; 1999 Apr; 27(4):259-62. PubMed ID: 10349766
[No Abstract] [Full Text] [Related]
13. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years.
D'Amato G; Caroppo E; Pasquadibisceglie A; Carone D; Vitti A; Vizziello GM
Fertil Steril; 2004 Jun; 81(6):1572-7. PubMed ID: 15193479
[TBL] [Abstract][Full Text] [Related]
14. The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone.
Scott RT; Elkind-Hirsch KE; Styne-Gross A; Miller KA; Frattarelli JL
Fertil Steril; 2008 Apr; 89(4):868-78. PubMed ID: 17603049
[TBL] [Abstract][Full Text] [Related]
15. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.
Fanchin R; Taieb J; Lozano DH; Ducot B; Frydman R; Bouyer J
Hum Reprod; 2005 Apr; 20(4):923-7. PubMed ID: 15640257
[TBL] [Abstract][Full Text] [Related]
16. Assessing fertility in women of advanced reproductive age.
Klein J; Sauer MV
Am J Obstet Gynecol; 2001 Sep; 185(3):758-70. PubMed ID: 11568811
[TBL] [Abstract][Full Text] [Related]
17. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
18. The number of basal antral follicles may predict ovarian responsiveness and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection treatment cycles.
Saleh A; Ayoub H; Faqeera F; Al-Mobrad B; Kayali M; Al-Shawa E
Fertil Steril; 2006 Aug; 86(2):473-6. PubMed ID: 16730006
[TBL] [Abstract][Full Text] [Related]
19. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
[TBL] [Abstract][Full Text] [Related]
20. We are overinterpreting the predictive value of serum follicle-stimulating hormone levels.
Barnhart K; Osheroff J
Fertil Steril; 1999 Jul; 72(1):8-9. PubMed ID: 10428140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
